Agilon Health (NYSE:AGL) Announces Earnings Results

Agilon Health (NYSE:AGL) posted its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.09), Zacks reports. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Agilon Health updated its FY 2025 guidance to EPS.

Agilon Health Trading Down 10.7%

NYSE:AGL opened at $0.72 on Wednesday. The company’s 50-day moving average is $1.06 and its two-hundred day moving average is $1.86. The firm has a market cap of $300.04 million, a price-to-earnings ratio of -0.94 and a beta of 0.05. Agilon Health has a 12-month low of $0.71 and a 12-month high of $6.08.

Hedge Funds Weigh In On Agilon Health

Large investors have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC raised its stake in Agilon Health by 214.0% during the second quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after purchasing an additional 25,270 shares during the period. Prudential Financial Inc. boosted its position in shares of Agilon Health by 70.7% in the second quarter. Prudential Financial Inc. now owns 40,880 shares of the company’s stock worth $94,000 after buying an additional 16,928 shares during the period. WINTON GROUP Ltd acquired a new stake in shares of Agilon Health in the second quarter valued at about $106,000. Dynamic Technology Lab Private Ltd raised its holdings in shares of Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after buying an additional 10,424 shares during the period. Finally, State of Wyoming lifted its position in Agilon Health by 31.1% during the 2nd quarter. State of Wyoming now owns 168,461 shares of the company’s stock worth $387,000 after acquiring an additional 39,952 shares in the last quarter.

Analyst Ratings Changes

Several research firms have recently weighed in on AGL. Jefferies Financial Group reduced their target price on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Benchmark decreased their price target on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, August 6th. Barclays reduced their price objective on Agilon Health from $3.00 to $1.50 and set an “underweight” rating for the company in a research note on Wednesday, August 6th. Sanford C. Bernstein reiterated a “market perform” rating and set a $1.40 price target (down from $4.00) on shares of Agilon Health in a research note on Wednesday, August 20th. Finally, Evercore ISI lowered their price target on shares of Agilon Health from $5.00 to $3.00 and set an “in-line” rating on the stock in a research note on Wednesday, July 9th. Four analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $2.81.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.